Swiss Chemicals Stock News

SWX:MEDX
SWX:MEDXMedical Equipment

Medmix (SWX:MEDX) Stock Faces Tiny Profit After One Off Loss Tests Bullish Narratives

medmix (SWX:MEDX) has reported H1 2026 results with trailing 12 month revenue of CHF437 million and net income of CHF0.1 million, translating to EPS of CHF0.002. The latest reported half year for 2025 showed revenue of CHF222.6 million and a net loss of CHF0.4 million, or EPS of CHF0.0096. Over the last few reported periods, revenue has moved from CHF242.7 million in H2 2024 to CHF225.4 million in H1 2025 and CHF222.6 million in H2 2025. Over the same timeframe, EPS shifted from a loss of...
SWX:LEON
SWX:LEONCapital Markets

Leonteq (SWX:LEON) Stock Faces Widening Losses Challenging Bullish Earnings Recovery Narrative

Leonteq (SWX:LEON) has kicked off H1 2026 earnings season with a mixed picture, as trailing 12 month figures show total revenue of CHF157.7 million alongside a loss of CHF30.3 million in net income and a basic EPS loss of CHF1.70, while the most recent reported half year in 2025 showed H2 revenue of CHF46.7 million with a net income loss of CHF43.0 million and basic EPS loss of CHF2.42. Over recent halves, total revenue has ranged from CHF104.3 million in H2 2024 to CHF123.7 million in H1...
SWX:ROP
SWX:ROPPharmaceuticals

Roche (SWX:ROG) Stock Margin Expansion To 19.6% Tests Bullish Earnings Narratives

Roche Holding (SWX:ROG) has reported its H1 2026 results with trailing twelve month revenue of CHF 62.96 billion and net income of CHF 12.34 billion, while the latest half year period shows revenue of CHF 31.51 billion, net income of CHF 5.47 billion and basic EPS of CHF 6.87. Over recent half year periods, the company has seen revenue move from CHF 31.64 billion in H2 2024 to CHF 31.85 billion in H1 2025 and CHF 31.51 billion in H2 2025, alongside basic EPS shifting from CHF 2.53 to CHF 9.31...
SWX:CMBN
SWX:CMBNConsumer Finance

Cembra Money Bank (SWX:CMBN) Stock EPS Stability Reinforces Profitability‑Focused Narratives

Cembra Money Bank (SWX:CMBN) has reported H1 2026 total revenue of CHF 231.0 million and net income of CHF 92.3 million, with basic EPS at CHF 3.15, setting a clear marker for the latest half year. The company has seen half year revenue move from CHF 235.9 million in H1 2025 to CHF 232.7 million in H2 2025 and then to CHF 231.0 million in H1 2026. Over that same H1-to-H1 period, basic EPS shifted from CHF 2.97 to CHF 3.15, giving investors a straightforward picture of how top line and EPS...
SWX:VACN
SWX:VACNMachinery

VAT Group (SWX:VACN) Reports 102% Order Intake Growth, Is The Upside Already Priced In?

Why VAT Group Stock Is Back in Focus After New Guidance VAT Group (SWX:VACN) is back on investors’ radar after reporting 102% year over year growth in order intake, confirming higher full year 2026 sales and net income guidance, and outlining ongoing capacity expansion. See our latest analysis for VAT Group. At a share price of CHF650.6, VAT Group has given investors a 50.39% year to date share price return and a very large 1 year total shareholder return of 127.72%. Shorter term momentum has...
SWX:COPN
SWX:COPNPharmaceuticals

Cosmo (SWX:COPN) Stock Faces Trailing Loss That Tests Bullish Growth Narrative

Cosmo (SWX:COPN) has reported its H1 2026 results with trailing 12 month revenue of €102.7 million and a loss of €6.4 million, translating to an EPS loss of €0.38, while the current share price sits at CHF63.6. The company has seen revenue move from €130.6 million in H2 2024 to €52.5 million in H2 2025 on a half year basis, with EPS shifting from €3.73 to a loss of €0.10 over the same periods. This sets up a results season in which investors are weighing forecasted growth against pressure on...
SWX:SFSN
SWX:SFSNMachinery

SFS Group (SWX:SFSN) Stock Tests Bearish Narrative As H1 2026 EPS Outpaces Modest Revenue

SFS Group (SWX:SFSN) has reported H1 2026 revenue of CHF1.6b and basic EPS of CHF3.82, with trailing twelve month EPS at CHF6.60 on revenue of about CHF3.1b and net income of CHF256.4m, setting the scene for its latest earnings season update. The company has seen revenue move from CHF1.55b in H1 2025 to CHF1.57b in H1 2026, while basic EPS went from CHF2.86 to CHF3.82 over the same half yearly periods. This gives investors a clearer view of how recent profit trends compare with the trailing...
SWX:BYS
SWX:BYSMachinery

Bystronic (SWX:BYS) Stock Faces Ongoing Losses As Dividend Coverage Concerns Grow

Bystronic (SWX:BYS) has opened H1 2026 with trailing 12 month revenue of CHF 611.5 million and a net loss of CHF 41.4 million, setting a cautious tone around how efficiently recent sales are translating into earnings. The company has seen half yearly revenue move from CHF 317.4 million in H2 2024 to CHF 304.6 million in H1 2025 and CHF 308.6 million in H2 2025, while net losses over those periods shifted between CHF 46.8 million, CHF 12.9 million and CHF 16 million. Investors are likely to...
SWX:BBN
SWX:BBNCapital Markets

Bellevue Group (SWX:BBN) Stock Faces 51.7% DCF Discount Despite 81.3% Earnings Growth

Fresh from reporting its H1 2026 results, Bellevue Group (SWX:BBN) is coming off a trailing twelve month stretch where revenue totalled CHF 53.91 million and basic EPS reached CHF 0.319, alongside trailing earnings growth of 81.3% year on year. Over the past reported halves, the company has seen revenue move from CHF 33.685 million in H2 2024 to CHF 25.154 million in H1 2025 and CHF 27.653 million in H2 2025, while basic EPS shifted from CHF 0.130 to CHF 0.014 and then CHF 0.128 over the same...
SWX:GIVN
SWX:GIVNChemicals

Givaudan (SWX:GIVN) Stock Faces Margin Compression As Net Profitability Trails Bullish Narratives

Givaudan (SWX:GIVN) has put fresh numbers on the table for H1 2026, with revenue of CHF 3.8b and basic EPS of CHF 51.46 anchoring the latest set of results. The company has seen recent revenue move between CHF 3.6b and CHF 3.9b across the last three half year periods, while basic EPS has ranged from CHF 51.46 to CHF 64.18. This gives investors a clear view of how the top and bottom lines have tracked through the past year. With a trailing twelve month net profit margin of 12.9%, down from...
SWX:VATN
SWX:VATNBanks

Valiant Holding (SWX:VATN) Stock EPS Growth Supports Steady Swiss Bank Narrative

Valiant Holding (SWX:VATN) has put up another solid quarter, with Q2 2026 revenue at CHF 142.6m and net income of CHF 42.6m helping to lift trailing 12 month revenue to CHF 552.7m and net income to CHF 157.2m, while prior quarter figures included Q1 revenue of CHF 134.7m and Q4 2025 revenue of CHF 138.4m. Over the same trailing period, basic EPS sat at CHF 9.85 in Q1 2026 against CHF 9.80 in Q4 2025, giving investors a clearer view of earnings power alongside a net profit margin of 28.4% that...
SWX:NESN
SWX:NESNFood

Is Nestlé (SWX:NESN) Undervalued As Profit Fell And Its Portfolio Overhaul Expanded?

Nestlé (SWX:NESN) is back in focus after its half year 2026 report showed organic sales growth, a double digit drop in net profit, and a sharp share price reaction. See our latest analysis for Nestlé. The 1 day share price return of down 7.98% and 7 day return of down 6.17% show how sharply the market responded to Nestlé’s weaker half year profit and the planned Peranel joint venture, even though the year to date share price return of 3.73% and 1 year total shareholder return of 11.31% still...
SWX:TEMN
SWX:TEMNSoftware

Temenos (SWX:TEMN) Stock Faces Margin Compression Narrative After Q2 2026 Earnings

Temenos (SWX:TEMN) opened Q2 2026 with revenue of US$281.5 million and basic EPS of US$1.01, as investors weighed these fresh numbers against a trailing net profit margin of 17.5% versus 27.8% a year earlier. Over recent quarters the company has seen revenue move between US$232.2 million and US$314.6 million, while quarterly basic EPS has ranged from US$0.41 to US$2.34, setting a wide earnings backdrop for today’s release. With forecasts pointing to mid teens annual earnings growth and steady...
SWX:EFGN
SWX:EFGNCapital Markets

EFG International (SWX:EFGN) Stock Faces Margin Hit From 107.2m One Off Charge

EFG International (SWX:EFGN) has just posted its H1 2026 scorecard, anchored by trailing 12 month revenue of CHF 1.7b and net income of CHF 271.2m, with recent half year EPS prints of CHF 0.71 for H1 2025 and CHF 0.32 for H2 2025 setting the earnings run rate. Over the past reported halves, total revenue has moved from CHF 753.4m in H2 2024 to CHF 793.8m in H1 2025 and CHF 864.5m in H2 2025, while net income over those same periods came in at CHF 148.8m, CHF 212.4m and CHF 95.4m respectively...
SWX:SDZ
SWX:SDZPharmaceuticals

How Investors Are Reacting To Sandoz Group (SWX:SDZ) Leadership Overhaul In Generics Manufacturing And M&A

Sandoz Group AG recently reshaped its senior leadership, appointing Pascal Bouye to the Executive Committee to lead Generics Manufacturing & Supply, expanding Keren Haruvi’s remit to global M&A, and rotating several country and regional heads into new roles across key markets. This leadership refresh brings in deep supply-chain and transaction expertise from fast-moving consumer goods and prior M&A roles at Novartis, potentially influencing how Sandoz executes on manufacturing efficiency,...
SWX:ABBN
SWX:ABBNElectrical

ABB (SWX:ABBN) Stock May Be Fully Priced On Record Orders

ABB stock has delivered a strong 182.3% total return over the past five years, yet the latest Discounted Cash Flow (DCF) intrinsic value estimate now points to the shares trading at a premium, while market multiples suggest pricing is closer to fair. Over five years, ABB has returned 182.3%, which puts current investors in a very different position from those considering a fresh entry today. Recent acquisitions and investments, including the planned Rotork purchase and a minority stake in...
SWX:UBSG
SWX:UBSGCapital Markets

UBS (SWX:UBSG) Teams Up With MSCI To Build An AI Private Markets Platform

UBS Group and MSCI Inc. have entered into a partnership to build an AI-powered platform for private market data and analytics. The collaboration aims to improve transparency and efficiency in private markets by addressing data fragmentation and limited visibility. UBS will act as both a development partner and an early adopter of the new platform within its wealth and asset management businesses. UBS Group, traded as SWX:UBSG, is tying this AI-focused agreement to its broader push in wealth...
SWX:CPHN
SWX:CPHNPackaging

Top European Growth Companies With Insider Ownership In July 2026

As the European market navigates a landscape marked by mixed economic signals and fluctuating tech stocks, investors are keenly observing growth companies with strong insider ownership. In this environment, firms where insiders hold significant stakes can offer confidence in strategic direction and alignment of interests with shareholders.